From anti-inflammatory drugs through antifibrotic agents to lung transplantation: A long road of research, clinical attempts, and failures in the treatment of idiopathic pulmonary fibrosis

Chest

Volumn 122, Issue 3, 2002, Pages 759-761

  Selman, Moisés ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; PIRFENIDONE; PREDNISOLONE;

CELL FUNCTION; CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG TRANSPLANTATION; MEDICAL RESEARCH; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036385814     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.3.759     Document Type: Editorial

References (19)

1. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136-151
2. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157:199-203
3. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345:517-525
4. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995; 21:791-808
5. Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341:1264-1269
6. Iyer SN, Gurujeyalakshmi G, Giri SN. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999; 291:367-373
7. Kehrer JP, Margolin SB. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice. Toxicol Lett 1997; 90:125-132
8. Raghu G, Johnson WC, Lockhart D, et al. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label phase II study. Am J Respir Crit Care Med 1999; 159:1061-1069
9. Lanuza DM, Lefaiver CA, Farcas GA. Research on the quality of life of lung transplant candidates and recipients: an integrative review. Heart Lung 2000; 29:180-195
10. Stavem K, Bjortuft O, Lund MB et al. Health-related quality of life in lung transplant candidates and recipients. Respiration 2000; 67:159-165
11. Meyers BF, Lynch JP, Trulock EP et al. Single vs bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. Thorac Cardiovasc Surg 2000; 120:99-107
12. Sulica R, Teirstein A, Padilla ML. Lung transplantation in interstitial lung disease. Curr Opin Pulm Med 2001; 7:314-321
13. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155:789-818
14. Mogulkoc N, Brutsche MH, Bishop PW, et al. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001; 164:103-108
15. De Meester J, Smits JMA, Persijin GG, et al. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20:518-525
16. Dark JH. Priorities for lung transplantation. Lancet 1998; 351:4-5
17. Harari S, Simonneau G, DeJuli E, et al. Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation. J Heart Lung Transplant 1997; 16:460-463
18. King TE, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164:1171-1181
19. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:450-454